Free Trial

Danaher Co. (NYSE:DHR) Shares Sold by Intech Investment Management LLC

Danaher logo with Multi-Sector Conglomerates background

Intech Investment Management LLC lessened its holdings in Danaher Co. (NYSE:DHR - Free Report) by 32.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,455 shares of the conglomerate's stock after selling 3,594 shares during the quarter. Intech Investment Management LLC's holdings in Danaher were worth $2,073,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Legal & General Group Plc grew its position in Danaher by 2.4% during the 2nd quarter. Legal & General Group Plc now owns 5,964,031 shares of the conglomerate's stock worth $1,490,112,000 after purchasing an additional 139,989 shares during the period. Dimensional Fund Advisors LP raised its position in Danaher by 2.6% during the second quarter. Dimensional Fund Advisors LP now owns 3,398,649 shares of the conglomerate's stock valued at $849,195,000 after acquiring an additional 85,081 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Danaher by 22.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate's stock valued at $761,475,000 after acquiring an additional 563,546 shares during the period. Swedbank AB acquired a new position in Danaher in the first quarter valued at approximately $676,545,000. Finally, Blair William & Co. IL increased its holdings in shares of Danaher by 0.9% during the 2nd quarter. Blair William & Co. IL now owns 1,777,030 shares of the conglomerate's stock valued at $443,991,000 after purchasing an additional 15,766 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Wolfe Research upgraded shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 price objective for the company in a research report on Thursday, October 31st. Raymond James cut their price target on shares of Danaher from $310.00 to $300.00 and set an "outperform" rating for the company in a report on Wednesday, October 23rd. Robert W. Baird decreased their price objective on shares of Danaher from $278.00 to $277.00 and set an "outperform" rating on the stock in a report on Wednesday, October 23rd. Barclays reduced their price target on shares of Danaher from $285.00 to $275.00 and set an "equal weight" rating for the company in a research report on Wednesday, October 23rd. Finally, Stephens reiterated an "overweight" rating and set a $315.00 price objective on shares of Danaher in a research note on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $287.16.

Read Our Latest Research Report on DHR

Danaher Trading Up 1.0 %

Shares of NYSE DHR traded up $2.27 during midday trading on Monday, reaching $238.11. 1,098,068 shares of the stock were exchanged, compared to its average volume of 2,753,998. The stock has a market capitalization of $171.98 billion, a P/E ratio of 45.01, a PEG ratio of 4.34 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The company has a 50 day simple moving average of $258.15 and a 200 day simple moving average of $260.03. Danaher Co. has a twelve month low of $215.68 and a twelve month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm's quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the firm earned $2.02 earnings per share. As a group, equities analysts expect that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date was Friday, September 27th. Danaher's payout ratio is 20.61%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should you invest $1,000 in Danaher right now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Beyond Meat Stock: Not Beyond Hope?

Beyond Meat Stock: Not Beyond Hope?

In this video, we analyze why this once-popular plant-based food stock, Beyond Meat, could be a surprise rebound candidate despite its recent struggles.

Related Videos

3 Potential Short Squeezes: Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines